22nd Century Group Inc XXII

NAS: XXII | ISIN: US90137F1030 3/05/2024

1,670 USD (-0,60%)

(-0,60%) 3/05/2024

Grafiek 22nd Century Group Inc

Grafiek 22nd Century Group Inc

1 dag1d -0,60%
1 week1w -0,60%
1 maand1m 12,84%
3 maanden3m 854,29%
6 maanden6m 271,11%
1 jaar1j 128,77%
5 jaar5j -29,54%

22nd Century Group Inc in het nieuws

Toon enkel gratis nieuws

29 december 2021 · La FDA autorise la commercialisation des cigarettes VLN® de 22nd Century Group en tant que produit du tabac à risque modifié · Persbericht

19 maart 2021 · Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry · Persbericht

12 maart 2021 · 22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants · Persbericht

11 maart 2021 · 22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020 · Persbericht

5 maart 2021 · 22nd Century Group to Participate in Investor Conferences in March 2021 · Persbericht

4 maart 2021 · 22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants · Persbericht

25 februari 2021 · 22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 Results · Persbericht

24 februari 2021 · 22nd Century Group Provides Business Update Letter from CEO · Persbericht

10 februari 2021 · 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits · Persbericht

28 januari 2021 · 22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District · Persbericht

Profiel 22nd Century Group Inc

Gezondheidstechnologie

Productie van tabak

Werknemers: 58

Aandelen 22nd Century Group Inc

Beurswaarde: 13,27 miljoen USD

Effecten: 7,90 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe